CORC

浏览/检索结果: 共10条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 期刊论文
BMC CANCER, 2023, 卷号: 23
作者:  Cao, Fei;  Shi, Changsheng;  Zhang, Guofu;  Luo, Jun;  Zheng, Jiaping
收藏  |  浏览/下载:3/0  |  提交时间:2023/11/10
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer The REALITY Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2021
作者:  Lin, Yansong;  Qin, Shukui;  Li, Zhiyong;  Yang, Hui;  Fu, Wei
收藏  |  浏览/下载:57/0  |  提交时间:2022/01/25
Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation 期刊论文
CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 卷号: 93, 期号: 5, 页码: 934-948
作者:  Wang, Yu;  Peng, Cheng;  Wang, Guimin;  Xu, Zhijian;  Luo, Yongfeng
收藏  |  浏览/下载:16/0  |  提交时间:2020/07/01
Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation 期刊论文
Chemical biology & drug design, 2019, 卷号: 93, 期号: 5, 页码: 934-948
作者:  Wang, Yu;  Peng, Cheng;  Wang, Guimin;  Xu, Zhijian;  Luo, Yongfeng*
收藏  |  浏览/下载:21/0  |  提交时间:2019/12/28
Combined effects of Lenvatinib and iodine-131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress 期刊论文
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 卷号: 16, 期号: 4
作者:  Wang, Guoyu;  Zhuang, Juhua;  Ni, Jing;  Ye, Ying;  He, Saifei
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Combined effects of Lenvatinib and iodine-131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress 期刊论文
Experimental and therapeutic medicine, 2018, 卷号: 16, 页码: 3325-3332
作者:  Wang Guoyu[1];  Zhuang Juhua[2];  Ni Jing[3];  Ye Ying[4];  He Saifei[5]
收藏  |  浏览/下载:3/0  |  提交时间:2019/04/22
Lenvatinib plus checkpoint inhibitors in patients (pts) with advanced intrahepatic cholangiocarcinoma (ICC): Preliminary data and correlation with next-generation sequencing. 期刊论文
2018, 卷号: 36, 期号: 4
作者:  Lin, Jianzhen;  Shi, Weiwei;  Zhao, Songhui;  Hu, Jinwei;  Hou, Zheng
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/03
The first-line treatment for unresectable hepatocellular carcinoma patients: lenvatinib versus sorafenib, or beyond? 期刊论文
2018, 卷号: 7, 期号: 3, 页码: 221-224
作者:  Xie, Feihu;  Feng, Shi;  Sun, Lejia;  Mao, Yilei
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Lenvatinib plus checkpoint inhibitors in patients (pts) with advanced intrahepatic cholangiocarcinoma (ICC): Preliminary data and correlation with next-generation sequencing. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2018-02-01
作者:  Lin, Jianzhen;  Shi, Weiwei;  Zhao, Songhui;  Hu, Jinwei;  Hou, Zheng
收藏  |  浏览/下载:20/0  |  提交时间:2020/01/03
Lenvatinib enhances the antitumor effects of paclitaxel in anaplastic thyroid cancer 期刊论文
AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 卷号: 7, 页码: 903-912
作者:  Jing, Changxin;  Gao, Zhifei;  Wang, Rong;  Yang, Zhao;  Shi, Bingyin
收藏  |  浏览/下载:8/0  |  提交时间:2019/11/26


©版权所有 ©2017 CSpace - Powered by CSpace